Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy

Lancet
M A JacobsonR B Pollard

Abstract

In previous natural history studies and clinical trials, AIDS-related cytomegalovirus (CMV) retinitis has occurred primarily in patients with absolute CD4 counts of 50 cells/microL or less (0.05 x 10(9)/L) at the time of diagnosis. We report five patients identified from our clinical practices who were diagnosed with CMV retinitis while their CD4 counts were above 195 cells/microL. We also analysed, based on CD4 counts, 76 AIDS patients with newly diagnosed CMV retinitis whose CD4 lymphocyte enumerations were done in laboratories that maintained certification in a common external quality control programme. 5-24 weeks before retinitis was diagnosed, all five patients had had absolute CD4 lymphocyte counts of less than 85 cells/microL, and 4-7 weeks before diagnosis, all five patients had started taking highly active antiretroviral treatment (HAART) regimens. Only one (4%) of 27 patients enrolled in the trial between July, 1995, and February, 1996, had an absolute CD4 count of more than 50 cells/microL, and none of 27 had an absolute CD4 count of more than 100/microL on entry to the trial. However, from March, 1996 (when indinavir and ritonavir were approved by the FDA for marketing in the USA), to August, 1996, 14 (29%) of 49 pa...Continue Reading

References

Jan 23, 1992·The New England Journal of Medicine·UNKNOWN Studies of Ocular Complications of AIDS Research Group, UNKNOWN AIDS Clinical Trials Group
Sep 1, 1990·Reviews of Infectious Diseases·M S PasternackR H Rubin
Nov 1, 1994·The Journal of Infectious Diseases·K K HansenL Mathiesen

❮ Previous
Next ❯

Citations

Nov 17, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J LedesmaUNKNOWN BKV Study Group
Jul 27, 2001·Current Infectious Disease Reports·Asok Kurup, Francesca J. Torriani
May 23, 2003·Current Infectious Disease Reports·Matthias Stoll, Reinhold E. Schmidt
Nov 13, 2004·Current Infectious Disease Reports·Edward M Gardner, Elizabeth Connick
Mar 5, 2004·Survey of Ophthalmology·Tamara R Vrabec
Jan 5, 2002·American Journal of Ophthalmology·Douglas A JabsLarry D Hubbard
Aug 26, 1998·Antiviral Research·J W Cohen StuartR J Whitley
Dec 2, 1998·Antiviral Research·M D de JongS A Spector
Jan 31, 2002·Journal of Chromatography. B, Biomedical Sciences and Applications·B B Ba, M C Saux
Jan 15, 1999·Infectious Disease Clinics of North America·B LutzJ Landry
Jan 6, 2001·Infectious Disease Clinics of North America·W Tantisiriwat, W G Powderly
Nov 24, 1999·International Journal of Antimicrobial Agents·M Jouan, C Katlama
Apr 23, 2003·Trends in Microbiology·Martin ScholzJindrich Cinatl
Sep 21, 2001·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·P PriceM A French
Feb 19, 2000·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·W G Nichols, M Boeckh
Feb 7, 2001·Eye·N H al-YousufJ Ironside
Sep 23, 2006·Nature Clinical Practice. Neurology·David J RiedelAvindra Nath
Jul 1, 1997·Nature Medicine·A U Neumann, G Gorochov
Apr 26, 2000·Haemophilia : the Official Journal of the World Federation of Hemophilia·C GirmeniaA Cassone
Nov 27, 2001·Clinical & Experimental Ophthalmology·A D Gajdatsy, M L Tay-Kearney
Jul 10, 1997·The New England Journal of Medicine·M A Jacobson
Jul 23, 1998·The New England Journal of Medicine·E T Cunningham, T P Margolis
Dec 10, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·I MezzaromaF Aiuti
Mar 18, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S K CintiP H Kazanjian
Jul 6, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·V C ChengR M Chan
Apr 20, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J E KaplanJ L Jones
Apr 20, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J S Currier
Dec 19, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C ManegoldS Günther

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.